Xiangkun Han

2.3k total citations
18 papers, 1.6k citations indexed

About

Xiangkun Han is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangkun Han has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangkun Han's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Research Studies (4 papers). Xiangkun Han is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Research Studies (4 papers). Xiangkun Han collaborates with scholars based in China, United States and Canada. Xiangkun Han's co-authors include Hongbin Ji, Haiquan Chen, Yihua Sun, Rong Fang, Zhaoyuan Fang, William Pao, Yijun Gao, Fei Li, Fuming Li and Yan Ren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xiangkun Han

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangkun Han China 16 770 743 689 418 365 18 1.6k
Whitney Banach‐Petrosky United States 14 905 1.2× 638 0.9× 367 0.5× 264 0.6× 127 0.3× 16 1.4k
Karen G. Montgomery Australia 15 1.1k 1.5× 397 0.5× 528 0.8× 362 0.9× 96 0.3× 17 1.6k
Ian A.J. Lorimer Canada 21 710 0.9× 308 0.4× 518 0.8× 399 1.0× 102 0.3× 41 1.3k
Roxanne Toivanen Australia 15 597 0.8× 937 1.3× 558 0.8× 374 0.9× 112 0.3× 21 1.5k
Janni Mirosevich United States 12 866 1.1× 626 0.8× 342 0.5× 236 0.6× 89 0.2× 18 1.4k
Kai Wiechen Germany 14 533 0.7× 284 0.4× 337 0.5× 226 0.5× 378 1.0× 22 1.2k
Karsten Gravdal Norway 16 620 0.8× 354 0.5× 465 0.7× 330 0.8× 97 0.3× 28 1.2k
Ubaradka G. Sathyanarayana United States 17 1.1k 1.4× 498 0.7× 276 0.4× 323 0.8× 87 0.2× 22 1.4k
Alan Dart‐Loon Sihoe Hong Kong 6 502 0.7× 691 0.9× 796 1.2× 292 0.7× 77 0.2× 6 1.1k
Andrew B. Gladden United States 18 1.1k 1.4× 209 0.3× 724 1.1× 178 0.4× 575 1.6× 26 1.7k

Countries citing papers authored by Xiangkun Han

Since Specialization
Citations

This map shows the geographic impact of Xiangkun Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangkun Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangkun Han more than expected).

Fields of papers citing papers by Xiangkun Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangkun Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangkun Han. The network helps show where Xiangkun Han may publish in the future.

Co-authorship network of co-authors of Xiangkun Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangkun Han. A scholar is included among the top collaborators of Xiangkun Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangkun Han. Xiangkun Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fang, Zhaoyuan, Xiangkun Han, Yueqing Chen, et al.. (2023). Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation. Signal Transduction and Targeted Therapy. 8(1). 16–16. 17 indexed citations
2.
Yao, Shun, Hsin‐Yi Huang, Xiangkun Han, et al.. (2019). Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation. Oncogene. 38(36). 6354–6369. 14 indexed citations
3.
Hou, Shenda, Zhen Qin, Yang Liu, et al.. (2017). Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma. American Journal Of Pathology. 187(5). 954–962. 45 indexed citations
4.
Hou, Shenda, et al.. (2016). Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance. Protein & Cell. 8(3). 178–190. 26 indexed citations
5.
Hou, Shenda, Xiangkun Han, & Hongbin Ji. (2016). Squamous Transition of Lung Adenocarcinoma and Drug Resistance. Trends in cancer. 2(9). 463–466. 18 indexed citations
6.
Zhang, Wenjing, Yijun Gao, Fuming Li, et al.. (2015). YAP Promotes Malignant Progression of Lkb1 -Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin. Cancer Research. 75(21). 4450–4457. 76 indexed citations
7.
Li, Fuming, Xiangkun Han, Fei Li, et al.. (2015). LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response. Cancer Cell. 27(5). 698–711. 106 indexed citations
8.
Han, Xiangkun, Fuming Li, Zhaoyuan Fang, et al.. (2014). Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma. Nature Communications. 5(1). 3261–3261. 137 indexed citations
9.
Gao, Yijun, Wenjing Zhang, Xiangkun Han, et al.. (2014). YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression. Nature Communications. 5(1). 4629–4629. 92 indexed citations
10.
Fang, Rong, Chao Zheng, Yihua Sun, et al.. (2014). Integrative Genomic Analysis Reveals a High Frequency of LKB1 Genetic Alteration in Chinese Lung Adenocarcinomas. Journal of Thoracic Oncology. 9(2). 254–258. 24 indexed citations
11.
Zhang, Wenjing, Yijun Gao, Peixue Li, et al.. (2014). VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Research. 24(3). 331–343. 246 indexed citations
12.
Li, Chenguang, Rong Fang, Yihua Sun, et al.. (2011). Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers. PLoS ONE. 6(11). e28204–e28204. 168 indexed citations
13.
Li, Chenguang, Yihua Sun, Zhaoyuan Fang, et al.. (2011). Comprehensive Analysis of Epidermal Growth Factor Receptor Gene Status in Lung Adenocarcinoma. Journal of Thoracic Oncology. 6(6). 1016–1021. 17 indexed citations
14.
Li, Chenguang, Yihua Sun, Rong Fang, et al.. (2011). Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains. Journal of Thoracic Oncology. 7(1). 85–89. 76 indexed citations
15.
Gao, Yijun, Qian Xiao, Li Li, et al.. (2010). LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proceedings of the National Academy of Sciences. 107(44). 18892–18897. 154 indexed citations
16.
Gao, Bin, Yihua Sun, Junhua Zhang, et al.. (2010). Spectrum of LKB1, EGFR, and KRAS Mutations in Chinese Lung Adenocarcinomas. Journal of Thoracic Oncology. 5(8). 1130–1135. 80 indexed citations
17.
Sun, Yihua, Yan Ren, Zhaoyuan Fang, et al.. (2010). Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases. Journal of Clinical Oncology. 28(30). 4616–4620. 274 indexed citations
18.
Han, Xiangkun, et al.. (1996). [Inhibitory effects of gypenoside on rat heart and brain Na+, K+(-)ATPase activity].. PubMed. 21(5). 299–302, 320. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Whitney Banach‐Petrosky Breakdown of academic impact, for papers by Karen G. Montgomery Breakdown of academic impact, for papers by Ian A.J. Lorimer Breakdown of academic impact, for papers by Roxanne Toivanen Breakdown of academic impact, for papers by Janni Mirosevich Breakdown of academic impact, for papers by Kai Wiechen Breakdown of academic impact, for papers by Karsten Gravdal Breakdown of academic impact, for papers by Ubaradka G. Sathyanarayana Breakdown of academic impact, for papers by Alan Dart‐Loon Sihoe Breakdown of academic impact, for papers by Andrew B. Gladden
Rankless by CCL
2026